Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

HYO JIN LEE

Professor

Chungbuk National University

South Korea

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Pharmacotherapy

90%

Immunology

40%

Cancer Biology

60%

Oncology

60%

Adjuvant Therapy

40%

Targeted Therapy

40%

Ovarian Cancer

40%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles26

Engineering Bacterial Secretion Systems for Enhanced Tumor Imaging and Surgical Guidance

Article Link

Year:

2025

Attenuated Salmonella secreting interleukin-21 activates T-cells and induces anti-tumor effects

Article Link

Year:

2025

Tumour-specific delivery of ω-conotoxin MVIIA via engineered Salmonella for safe anticancer therapy

Article Link

Year:

2025

Nivolumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Korean Patients with HER2-Negative, Untreated, Unresectable Advanced or Recurrent Gastric or Gastroesophageal Junction Cancer: Subgroup Analysis of a Randomized, Multicenter, Double-Blind Phase 3 Trial (ATTRACTION-4)

Article Link

Year:

2025

GDF15 promotes gallbladder cancer progression by activating the NF-kB mediated Vascular Endothelial Growth Factor A (VEGFA) expression

Article Link

Year:

2025

First-line pembrolizumab-axitinib versus sunitinib in metastatic RCC: subgroup analysis of patients enrolled in the phase 3 KEYNOTE-426 in Eastern Asia

Article Link

Year:

2025

A Multicenter Phase II Study of Modified FOLFIRINOX for First-line Treatment for Advanced Urachal Cancer (ULTMA; KCSG GU20-03)

Article Link

Year:

2025

Outcomes by Retrospective Eligibility for Maintenance Therapy of Patients With Advanced Urothelial Carcinoma: Post Hoc Analysis of the Phase 3 KEYNOTE-361 Trial

Article Link

Year:

2025

Post-transplant cyclophosphamide plus anti-thymocyte globulin decreased serum IL-6 levels when compared with post-transplant cyclophosphamide alone after haploidentical hematopoietic stem cell transplantation

Article Link

Year:

2025

Controlling tumor progression and recurrence in mice through combined treatment with a PD-L1 inhibitor and a designer Salmonella strain that delivers GM-CSF

Article Link

Year:

2024

Phase II study of nivolumab in patients with genetic alterations in DNA damage repair and response who progressed after standard treatment for metastatic solid cancers (KM-06)

Article Link

Year:

2024

Effectiveness of Adding Docetaxel to Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer in Korean Real-World Practice

Article Link

Year:

2023

Efficacy of cisplatin combined with vinorelbine as second- or higher-line palliative chemotherapy in patients with advanced ovarian cancer

Article Link

Year:

2023

Hederacolchiside A1 Suppresses Autophagy by Inhibiting Cathepsin C and Reduces the Growth of Colon Cancer

Article Link

Year:

2023

GDF15 Promotes Cell Growth, Migration, and Invasion in Gastric Cancer by Inducing STAT3 Activation

Article Link

Year:

2023

The Frontline Immunotherapy-Based Treatment of Advanced Clear Cell Renal Cell Carcinoma: Current Evidence and Clinical Perspective

Article Link

Year:

2022

Volumetric Splenomegaly in Patients With Polycythemia Vera

Article Link

Year:

2022

Loss of Von Hippel–Lindau (VHL) Tumor Suppressor Gene Function: VHL–HIF Pathway and Advances in Treatments for Metastatic Renal Cell Carcinoma (RCC)

Article Link

Year:

2021

Perioperative Systemic Treatment for Muscle-Invasive Bladder Cancer: Current Evidence and Future Perspectives

Article Link

Year:

2021

MITF Promotes Cell Growth, Migration and Invasion in Clear Cell Renal Cell Carcinoma by Activating the RhoA/YAP Signal Pathway

Article Link

Year:

2021

Dsg2-mediated c-Met activation in anaplastic thyroid cancer motility and invasion

Article Link

Year:

2020

A comparison of post-transplantation cyclophosphamide versus antithymocyte-globulin in patients with hematological malignancies undergoing HLA-matched unrelated donor transplantation

Article Link

Year:

2020

Efficacy of cisplatin combined with topotecan in patients with advanced or recurrent ovarian cancer as second- or higher-line palliative chemotherapy

Article Link

Year:

2020

Efficacy of cisplatin combined with topotecan in patients with advanced or recurrent ovarian cancer as second- or higher-line palliative chemotherapy

Article Link

Year:

2020

Adrenal insufficiency due to recurrent renal cell carcinoma in the left adrenal gland 3 years after right radical nephrectomy for renal cell carcinoma

Article Link

Year:

2020

Alteration of CYP4A11 expression in renal cell carcinoma: Diagnostic and prognostic implications

Article Link

Year:

2020

Collaborators11

Ji Youl Lee

SOUTH KOREA

Ik-Chan Song

Chungbuk National University

SOUTH KOREA

Jeong Eun Lee

Prof.

Chungbuk National University

SOUTH KOREA

Daejin lim

Kangnam University

SOUTH KOREA

Heung Jin Jeon

Chonnam National University

SOUTH KOREA

Kwonoh Park

Professor

Pusan National University Yangsan Hospital

SOUTH KOREA

Jung-Hyun Lee

Professor

Korea University

SOUTH KOREA

Kyung Sook Shin

Seoul National University Hospital

SOUTH KOREA

Deog-Yeon Jo

Chungnam National University School of Medicine

SOUTH KOREA

Dong Ha Kim

Prof.

Ewha Womans University

SOUTH KOREA

Jae Lyun Lee

University of Ulsan College of Medicine

SOUTH KOREA

How do I reach out?

Meet Kite AI